6家破产的中小药企:由Third rock、吉利德投资的肾病药物生公司Goldfinch Bio、从诺华分拆出来的抗生素公司Nabriva Therapeutics、从武田引入管线的Cali...查看全文
药时代2023-01-29 14:08
01 谁折去了金翅雀的翅膀?
2023年1月27日,一家名为Goldfinch Bio(金翅雀)的Biotech正在走ABCs破产程序。
(ABCs程序即一种新型破产程序,与清算不同的是:ABC清偿完毕债务人债权后,如有剩余现金,在不产生新债务的前提下受托人可以保持企业继续经营。与重组不同的是:在ABC程序中,有...查看全文
同写意2023-01-24 23:02
撰文丨Daisy
编辑丨于靖
如果要为过去一年选定医药行业关键词,裁员是绕不开的一个。
2022年,据Fierce Biotech统计,全球有超过100家医药企业宣布裁员。这波浪潮在11月达到顶峰,当月共有23家公司报告了裁员事件。而在国人求职的“金三银四”时节,裁员公司的数量也多达17家。
导...查看全文
Calithera(CALA)2023-01-09 21:12
$Calithera(CALA)$ 8-K Current report, items 2.05, 5.02, and 9.01 Accession Number: 0001193125-23-004182 Act: 34 Size: 173 KB 网页链接查看全文
Calithera(CALA)2022-07-06 18:21
$Calithera(CALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001395064-22-000119 Size: 12 KB 网页链接查看全文
Calithera(CALA)2022-04-01 04:21
$Calithera生物科学(CALA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-22-091746 Act: 34 Size: 216 KB 网页链接查看全文
Calithera(CALA)2023-03-20 18:12
$Calithera(CALA)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-000597 Act: 33 Size: 1 KB 网页链接查看全文
Calithera(CALA)2023-03-15 04:12
$Calithera(CALA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-070138 Act: 33 Size: 28 KB 网页链接查看全文
Calithera(CALA)2023-03-15 04:06
$Calithera(CALA)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-23-070124 Act: 33 Size: 19 KB 网页链接查看全文
Calithera(CALA)2023-03-15 04:12
$Calithera(CALA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-070142 Act: 33 Size: 28 KB 网页链接查看全文
薛定锷之猫2017-03-02 10:14
$Calithera Biosciences, Inc.(CALA)$ 两个重磅抗癌药物都是跟现有抗癌药合用:
cb-839:现跟3个已批抗癌药合用,主治肾癌RCC,目前均在1b期;
跟另2个已批药合用,分别治3阴乳腺癌TNBC(2017年中1b上部分,1b下部分2017年中到18年底)和大肠癌(1b2017年到2018中)
cb-1158:跟incyte合作...查看全文
善行的存钱小木屋2017-02-05 19:27
上证决策参考20170206
【本期导读】
险资投资股市规模将持续稳升
受访基金更看好行业龙头公司
部分厂家节后上调海绵钛价格
美生物科技板块近期表现突出
【主编观点】
险资投资A股规模将持续稳升
节前保监部门明确了强化险资股票投资监管的相关举措,这有助于...查看全文
小目标吖2017-02-05 00:40
$Calithera Biosciences, Inc.(CALA)$
HC Wainwright set a $10.00 target price on Calithera Biosciences, Inc. (NASDAQ:CALA) in a research report sent to investors on Thursday morning. The brokerage currently has a buy rating on the stock.
Several other research analyst...查看全文
小目标吖2017-02-04 12:33
回复@跳空涨停: $Calithera Biosciences, Inc.(CALA)$ 好冷清,哈哈//@跳空涨停:回复@跳空涨停:目前回头看所有技术指标都是超级牛股的走势,唯一的问题是最近两天都是尾盘无量拉升。查看全文
以静制动20152017-02-04 10:35
$Calithera Biosciences, Inc.(CALA)$ • Thinly traded nano cap Calithera Biosciences (NASDAQ:CALA) is up 35% premarket, albeit on only 750 shares, in response to its announcement of a global collaboration and license agreement with Incyte (NASDAQ:INCY) research, develop and ...查看全文
小目标吖2017-01-31 19:27
$Calithera Biosciences, Inc.(CALA)$ Shares of Calithera Biosciences Inc. (CALA) saw a solid gain early on Monday after the company reported a global collaboration and licensing agreement with Incyte Corp. (INCY). Ultimately, this agreement is working toward the commercializa...查看全文
小目标吖2017-01-31 19:06
$Calithera Biosciences, Inc.(CALA)$ Incyte Corp. entered into a global collaboration and license agreement, potentially valued at more than $483 million, for an experimental cancer therapy being developed by Calithera Biosciences Inc. Under the terms of the deal Incyte (NASDA...查看全文
SVB证券分析师Jonathan Chang将Calithera Biosciences(CALA)从增持下调至“与大市同步”,目标价从18美元下调至2美元。 此前该公司宣布mivavotinib和sapanisertib II期研究的初步数据预计将在2023年中期,这将超出2023年第二季度的现金流。... 网页链接
$Calithera(CALA)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-000597 Act: 33 Size: 1 KB 网页链接
$Calithera(CALA)$ 15-12G Securities registration termination [Section 12(g)] Accession Number: 0001193125-23-070159 Act: 34 Size: 10 KB 网页链接
$Calithera(CALA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-070145 Act: 33 Size: 28 KB 网页链接
$Calithera(CALA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-070147 Act: 33 Size: 28 KB 网页链接
$Calithera(CALA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-070150 Act: 33 Size: 28 KB 网页链接
$Calithera(CALA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-070152 Act: 33 Size: 28 KB 网页链接
$Calithera(CALA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-070155 Act: 33 Size: 28 KB 网页链接
$Calithera(CALA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-070129 Act: 33 Size: 28 KB 网页链接
$Calithera(CALA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-070136 Act: 33 Size: 28 KB 网页链接
$Calithera(CALA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-070138 Act: 33 Size: 28 KB 网页链接